GLP-1 Market
LLY $1288.30 ▲ +0.5% NVO $38.29 ▼ -1.0% PFE $29.45 ▼ -1.2% VKTX $25.36 ▲ +1.9% KLRA $13.42 ▲ +2.2% GPCR $21.48 ▼ -0.3% RHHBY $60.22 ▼ -0.2%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

ABP-745 Dose B

ABP-745 Dose B

Company
Atom Therapeutics Co., Ltd
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 29, 2026

Find a Clinical Trial Near Me

See recruiting studies for ABP-745 Dose B and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT07303777

    Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

    Not yet reported Atom Therapeutics Co., Ltd 200 participants Est. completion 2028-04 33 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT07145229

    Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

    Not yet reported Atom Therapeutics Co., Ltd 479 participants Est. completion 2026-08-11 38 sites Stand-alone
    Other conditions: Acute Gouty Arthritis, Gout Flare, Gout Flares, Acute Gout Flare
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.